Skip to main content

Table 7 Assay of tablets

From: Stability-indicating method development and validation for the concurrent determination of darunavir, cobicistat, emtricitabine and tenofovir alafenamide by UPLC in bulk and tablet dosage forms

Drug Label claim (mg/tab) Amount found (mg) % assay
TAF 10 9.97 99.66
COBI 150 150 100.00
FTC 200 200.44 100.22
DRV 800 802.4 100.30
  1. TAF tenofovir alafenamide, COBI cobicistat, FTC emtricitabine, DRV darunavir, % percentage, mg/tab milligram/tablet